NCT01679899View on ClinicalTrials.gov

Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type 2 Diabetes MellitusMenopauseOsteoporosisOsteopenia
Interventions
DRUG

Vildagliptin

Vildagliptin 50mg bid orally for 12 months

DRUG

Gliclazide MR

Gliclazide MR 60 or 120mg orally for 12 months

Trial Locations (1)

80810040

Centro de Diabetes Curitiba, Curitiba

All Listed Sponsors
lead

Centro de Diabetes Curitiba Ltda

OTHER

NCT01679899 - Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability | Biotech Hunter | Biotech Hunter